These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3871218)

  • 1. Treatment of murine lupus with monoclonal anti-T cell antibody.
    Wofsy D; Ledbetter JA; Hendler PL; Seaman WE
    J Immunol; 1985 Feb; 134(2):852-7. PubMed ID: 3871218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
    Wofsy D
    J Immunol; 1986 Jun; 136(12):4554-60. PubMed ID: 3086436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
    Carteron NL; Schimenti CL; Wofsy D
    J Immunol; 1989 Mar; 142(5):1470-5. PubMed ID: 2521880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
    Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
    J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
    Asensi V; Kimeno K; Kawamura I; Sakumoto M; Nomoto K
    Immunology; 1989 Oct; 68(2):204-8. PubMed ID: 2478453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D; Seaman WE
    J Immunol; 1987 May; 138(10):3247-53. PubMed ID: 3106478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo.
    Mountz JD; Gause WC; Finkelman FD; Steinberg AD
    J Immunol; 1988 May; 140(9):2943-9. PubMed ID: 2834447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of murine lupus in CD4-depleted NZB/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity.
    Connolly K; Roubinian JR; Wofsy D
    J Immunol; 1992 Nov; 149(9):3083-8. PubMed ID: 1357036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thymectomy on lupus-prone mice.
    Hang L; Theofilopoulos AN; Balderas RS; Francis SJ; Dixon FJ
    J Immunol; 1984 Apr; 132(4):1809-13. PubMed ID: 6142069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of CD4+ T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice.
    O'Sullivan FX; Vogelweid CM; Besch-Williford CL; Walker SE
    J Autoimmun; 1995 Apr; 8(2):163-75. PubMed ID: 7612146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
    Scott DE; Kisch WJ; Steinberg AD
    J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to tolerance induction is not prerequisite to development of murine SLE.
    Izui S; Masuda K
    J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.